New shot could ease hay fever misery for millions
NCT ID NCT07199257
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 28 times
Summary
This study tests a new medicine called GR1802, given as an injection alongside standard allergy treatments, for people with seasonal allergic rhinitis (hay fever). The goal is to see if it can better control symptoms like sneezing, runny nose, and itchy eyes. About 144 adults who have had seasonal allergies for at least 2 years and have not been well-controlled with current treatments will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS, SEASONAL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongnan Hospital of Wuhan university
Wuhan, Hubei, 430000, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.